Abstract
The H2N2 influenza A virus subtype was responsible for the 1957-58 Asian pandemic but ceased human circulation in 1968. With waning global immunity, the potential re-emergence of H2 strains from avian reservoirs is a significant public health concern. A critical step in cross-species transmission is the adaptation of the viral hemagglutinin (HA) to human-type glycan receptors (α2-6-linked sialic acids). This study investigates the molecular determinants of this specificity switch in modern avian H2N2 strains, which have diverged significantly from the 1957 pandemic ancestor. Using structural modeling and quantitative binding assays, we identify a set of mutations—specifically at positions 137 and 193—that, in combination with classic mutations at 226 and 228, confer human-like receptor affinity to contemporary avian H2N2 HA.
Introduction
Influenza pandemics occur when a novel virus to which humans have little immunity jumps from an animal reservoir. The H2N2 pandemic of the late 1950s is a prime example. While H1N1 and H3N2 subtypes continue to circulate, H2N2 has been absent for over five decades, leaving individuals born after 1968 immunologically naive. Because H2 subtypes remain endemic in birds and occasionally infect pigs, the risk of a "shift" or "drift" event leading to human re-infection is constant.
The primary barrier to this jump is the HA protein's receptor binding specificity. Avian viruses typically target α2-3-linked sialic acids in the bird gut, whereas human-adapted viruses target α2-6-linked sialic acids in the upper respiratory tract. Understanding the exact mutations required for this switch in modern avian backgrounds is essential for effective genomic surveillance.
Methods and Materials
The research team utilized a multi-disciplinary approach to map the binding landscape of H2N2:
- Quantitative Glycan Array Binding: The researchers employed a dose-dependent platform to calculate an apparent binding constant ($K_d'$), accounting for the multivalent nature of viral attachment.
- Human Tissue Staining: Recombinant HA proteins were applied to human tracheal and alveolar tissue sections to validate array results in a biological context.
- Homology Modeling: 3D models of HA from a 2004 chicken isolate (CkPA04) were constructed using PDB templates (2WR7, 2WR2) to visualize structural interactions.
- Site-Directed Mutagenesis: Mutations were systematically introduced into the CkPA04 HA to transform its binding profile to match the 1957 pandemic reference strain (Alb58).
Results
A key finding was that the pandemic Alb58 HA is a "generalist," maintaining high affinity for human receptors while retaining significant binding to avian receptors. In contrast, the baseline avian strain CkPA04 showed negligible human receptor binding.
Interestingly, introducing the "classic" mutations at positions 226 and 228 (the LS mutant) into the modern avian background only partially restored human binding. The resulting affinity ($K_d' \approx 50$ pM) was nearly 10-fold weaker than that of the Alb58 strain ($K_d' \approx 5$ pM).
The study identified that additional mutations at positions 137 (Gln → Arg) and 193 (Ala → Thr) were necessary to bridge this gap. These residues are located on the periphery of the binding pocket and interact with the glycan chain beyond the initial sialic acid linkage. The triple mutant (TLS: 193+226+228) and quadruple mutant (RTLS: 137+193+226+228) successfully boosted human receptor affinity to the 3–8 pM range, matching the pandemic strain's performance.
Tissue staining confirmed these results. While the wild-type avian HA primarily stained the deep lung (alveoli), the human-adapted RTLS mutant showed extensive staining on the apical surface of the human trachea, a hallmark of viruses capable of human-to-human transmission.
Discussion and Conclusion
This research highlights that sequence divergence in modern avian strains necessitates a more complex set of mutations for human adaptation than previously thought. The identification of residues 137 and 193 as critical determinants provides a specific "watchlist" for public health officials monitoring avian influenza.
While these findings demonstrate the biochemical potential for human adaptation, further research is needed to determine if these mutations also support efficient viral replication and aerosol transmission in vivo. Nevertheless, this study significantly advances our ability to assess the pandemic risk posed by circulating H2N2 avian influenza viruses.
Summary updated